WhatsNew2Day - Latest News And Breaking Headlines
Take a fresh look at your lifestyle.

Moderna Aims to DOUBLE COVID-19 Vaccine Production and Deliver 40 Million Doses Per Month

The US could get MORE 100 million doses of covid vaccine this spring: Moderna aims to DOUBLE production to 40 million doses per month by April, while Johnson & Johnson says it could deliver 20 million doses of its one-time vaccine next month if gets the FDA green light

  • In January, Moderna produced 19.1 million doses of US coronavirus vaccines, tripling its monthly production from October to December.
  • By April, the companies hope to double this amount and deliver between 40 and 50 million doses per month
  • Johnson & Johnson said it could deliver 20 million doses of its one-time vaccine to the US next month in a written statement ahead of a Congressional hearing.
  • The company reiterated it will have the capacity to deliver 100 million doses of vaccine to the country by the end of June
  • Two coronavirus vaccine manufacturers say they will step up to provide more doses to the US as officials ramp up immunization efforts Monday.

    On Monday, Moderna Inc said it plans to double its monthly vaccine deliveries from about 20 million a month to 40 million by April.

    Meanwhile, drugmaker Johnson & Johnson says it will be able to deliver 20 million doses to America for its single-shot COVID-19 vaccine by the end of March, assuming it gets the green light from federal regulators.

    In April, Moderna hopes to double the number of doses of coronavirus vaccines it delivers to the US from approximately 20 million a month to 40 million doses (above)

    In April, Moderna hopes to double the number of doses of coronavirus vaccines it delivers to the US from approximately 20 million a month to 40 million doses (above)

    Johnson & Johnson said it could deliver 20 million doses of its one-time vaccine to the US next month in a written statement ahead of a Congressional hearing on Tuesday. Pictured: J&J vaccine vials against COVID-19 seen at Klerksdorp Hospital in South Africa, Feb. 18

    Johnson & Johnson said it could deliver 20 million doses of its one-time vaccine to the US next month in a written statement ahead of a Congressional hearing on Tuesday. Pictured: J&J vaccine vials against COVID-19 seen at Klerksdorp Hospital in South Africa, Feb. 18

    Johnson & Johnson said it could deliver 20 million doses of its one-time vaccine to the US next month in a written statement ahead of a Congressional hearing on Tuesday. Pictured: J&J vaccine vials against COVID-19 seen at Klerksdorp Hospital in South Africa, Feb. 18

    Last year, the federal government struck a deal with Moderna for $ XX billion in exchange for 200 million doses of the company’s vaccine.

    This was expanded to 300 million doses after President Joe Biden ordered his administration to secure an additional 100 million doses.

    Moderna aims to double vaccine deliveries to the US government by April.

    The company scaled up production, producing 17.8 million doses between October and the end of December, and 19.1 million doses in January alone – tripling its monthly production.

    From April to the end of July, Moderna hopes to double this number, at 40 to 50 million doses per month.

    Moderna expects to deliver 100 million doses to the US by the end of May 2021, followed by an additional 100 million doses by the end of July 2021.

    It comes as J&J announced that it should be able to provide 20 million doses to the US if approved by the Food and Drug Administration (FDA).

    J&J released the figure in written testimony ahead of a Congressional hearing on Tuesday about the country’s vaccine stockpile. White House officials last week warned that initial supplies of J & J’s vaccine would be limited.

    The company reiterated that it will have the capacity to deliver 100 million doses of vaccine to the US by the end of June.

    The daily average of vaccinations has dropped to 1.2 million a day, but it still looks like President Joe Biden will reach his goal of 100 million shots in the arms in the first 100 days of his term.

    The daily average of vaccinations has dropped to 1.2 million a day, but it still looks like President Joe Biden will reach his goal of 100 million shots in the arms in the first 100 days of his term.

    The daily average of vaccinations has dropped to 1.2 million a day, but it still looks like President Joe Biden will reach his goal of 100 million shots in the arms in the first 100 days of his term.

    Currently, 44.1 million people - 13.4% of the US population - have received at least one dose and 19.4 million - 5.9% - have received two doses

    Currently, 44.1 million people - 13.4% of the US population - have received at least one dose and 19.4 million - 5.9% - have received two doses

    Currently, 44.1 million people – 13.4% of the US population – have received at least one dose and 19.4 million – 5.9% – have received two doses

    That stock will help government officials meet the goal of getting enough injections later this year to vaccinate most adult Americans. Worldwide, the company wants to produce a billion doses this year.

    US health regulators are still assessing the shot’s safety and effectiveness, and a decision to allow its emergency use later this week is expected.

    J & J’s vaccine would be the first vaccine in the US to require only one injection, compared to currently available vaccines from Pfizer and Moderna, which require two doses three to four weeks apart.

    Currently, 44.1 million people – 13.4 percent of the US population – have received at least one dose, and 19.4 million – 5.9 percent – have received two doses.

    The daily average of vaccinations has dropped to 1.2 million a day, but it still looks like President Joe Biden will reach his goal of 100 million shots in the arms in the first 100 days of his term.

    Advertisement